Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Commercial
Pricing
Pricing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pricing
Biden, Harris Unveil Prescription Drug Pricing Plans
Biospace News
-
July 16, 2019
Pricing
It May be Too Late for Meaningful Drug Pricing Legislation this Year
Pricing
US Democratic hopeful Amy Klobuchar proposes drug cost plan aimed at seniors ...
Pricing
US Democratic hopeful Amy Klobuchar proposes drug cost plan aimed at seniors ...
Pricing
U.S. Companies Continue to Pay More in Healthcare as the Cost of Drugs Keeps Rising
Pricing
Despite Political Rhetoric, Some Drug Prices Jumped on July 1, Including...
Biospace News
-
July 2, 2019
0
Pricing
Despite Drug Pricing Concerns, Poll Shows Americans Tolerate High Costs of...
Biospace News
-
June 27, 2019
0
Pricing
Prescription Medication Costs Shaping Up to Become Central Issue in Election
Biospace News
-
June 25, 2019
0
Pricing
ICER calls price of Novartis’ Mayzent “far out of line” with...
Firstwordpharma News
-
June 21, 2019
0
Pricing
Novartis to charge $2.1 million for Zolgensma following its US approval...
Firstwordpharma News
-
May 24, 2019
0
1
2
3
...
9
Page 1 of 9
- Advertisement -
MOST POPULAR
BioSpace’s Hot 8 Life Science Locations for Jobs
April 9, 2019
Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership
March 20, 2019
Regeneron Discloses Two Deaths from its Bispecific Antibody RGN1979
May 8, 2019
Orexo Interim Report Q2 2019
July 11, 2019
Load more
HOT NEWS
Phase III
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for...
Immuno-oncology
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands...
Others
China Has Big Presence in Top 10 Biotech IPOs this Year
Others
Cutbacks by some doctors halved new opioid prescriptions over 5 years ...
